Compass Pathways Plc (CMPS)
9.39
-0.37
(-3.79%)
USD |
NASDAQ |
May 07, 16:00
9.34
-0.05
(-0.53%)
After-Hours: 07:26
Compass Pathways Research and Development Expense (Annual) : 118.71M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Definium Therapeutics, Inc. | 117.66M |
| GH Research Plc | 38.73M |
| Atai Beckley, Inc. | 53.06M |
| Nektar Therapeutics | 117.07M |
| Silence Therapeutics Plc | 60.29M |